Experience with Isoxsuprine in the Treatment of Sickle Cell Crisis: A Proposed Mechanism of Action

Abstract

An accidental clinical observation triggered this investigation into the possible beneficial effects of isoxsuprine in the treatment of painful sickle cell crisis.

Twenty-four patients were studied with a total of 34 episodes of painful crisis. As they had all been previously treated by us we knew the duration of their crisis under conventional treatment, so that the two regimens with and without isoxsuprine could be compared. Isoxsuprine was administered in 3 successive steps: (1) as an IM injection (5-10 mg), (2) as a rapid IV infusion (1 mg/minute), and (3) as a slow, continuous IV infusion (0.1-0.3 mg/minute).

The results from this study suggest that isoxsuprine exerts in fact a remarkable action in sickle cell crisis by bringing about prompt relief in approximately 80% of the cases within 5 hours, and in 40% of the cases within 2 hours. There were only 2 cases of absolute failure.

The hospitalization time was remarkably reduced and the use of narcotics was minimized. Side effects (tachycardia, palpitations, somnolence) have been observed mainly in cases where relatively high doses of isoxsuprine had to be administered IV.

Get full access to this article

View all access options for this article.

References

Diggs, L.W. : Sickle cell crises. Am. J. Clin. Pathol., 44: 1, 1965.

Finch, C.A. : Pathophysiologic aspects of sickle cell anemia. Am. J. Med. , 53: 1, 1972.

Klug, P.P. , Lessin, L.S. : Rheological aspects of sickle cell disease. Arch. Intern. Med., 133: 577, 1974.

Segel, G.B. , Feig, S.A. , Mentzer, W.C. , et al.: Effects of urea and cyanate on sickling "in vitro". N. Engl. J. Med., 287: 59, 1972.

Cerami, A. , Manning, J.M. : Potassium cyanate as an inhibitor of the sickling of erythrocytes in vivo Proc. Nat. Acad. Sci. Wash., 68: 1180, 1971 .

Papayannopoulou, Th. , Stamatoyannopoulos, G., Giblet, E., Anderson, J.: Tissue isozyme alterations in Cyanate treated animals. Life Sci., 12: 127, 1973.

Kimmelstiel, P. : Vascular occlusions and ischemic infarction in sickle-cell disease. Am. J. Med. Sci., 216: 11, 1948.

Diggs L.W. and Williams D.L. : Treatment of painful Sickle cell Crises with Papaverine. A Preliminary Report. South Med. J., 56:472, 1949.

Smith E., Rosenblatt Ph. and Bedo A. V.: Sickle-cell anemia crisis. Report on seven Patients Treated with Priscoline. J. Pediatr. 43:655, 1953.

10.

Athitakis C. , Pyrgas S. , Mavrommatis G. , Zoga P. and Vorias N. : Action of Xathinol Nicotinate on the sickling phenomenon of erythrocytes in vivo. Arch. Hellen. Med. Soc. 1:243, 1975.

11.

Begue P. , Bertrand E. , Bonhomme J. , David M. , Coullet Y. , Pierredon M. et Sna Kale M.: Action de la dihydroergotoxine sur la crise drèpanocytaire. Nouv. Presse Med. p. 2449, 1978.

12.

Kaindl, F. , Samuels, S.S. , Selman, D. , Shaftel, H. : A new vasodilating and antispasmodic agent: isoxsuprine-HCl. Angiology, 10: 185, 1959.

13.

Dhrymiotis, A.D. , Whittier, J.R. : Effect of a vasodilator, isoxsuprine, on cerebral ischemic episodes. Curr. Ther. Res., 4: 124, 1962.

14.

Whittier, J.R. : Vasorelaxant drugs and cerebrovascular disease . Angiology, 15: 82, 1964.

15.

Scebat, L. : A study of the haemodynamic effect of a new vasodilator drug, CAA 40. La Presse Medicale 69: 338, 1961.

16.

Schlichting, K. , Heidrich, H. : Einfluss von Isoxsuprin auf die Blutviskosität . Vasa, 5: 51, 1976.

17.

Di Perri, T. , Forconi, S. , Agnusdei, D. , Guerrini, M. Laghi Pasinin, F. : The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease. Br. J. Clin. Pharmacol., 5: 255, 1978.

18.

Fdez, J. , De Quiros, B. , Hess, H. : Über den Einfluss von Isoxsuprine-Hcl auf die Fliessfähigkeit des Blutes. Fortschr. Med., 29: 1661, 1976.

19.

Harris, J.W. , Brewster, H.H. , Ham, H.T. , Castle, W.B. : Studies on the destruction of red blood cells. X: The biophysics and biology of sickle-cell disease. Arch. Intern. Med., 97: 145, 1956.

20.

Leight, L. , Snider, T.H. , Clifford, G.O. , Hellems, H.K. : Hemodynamic studies in sickle cell anemia. Circulation, 10: 653, 1954.

21.

Jensen, W.N. , Rucknagel, D.L. , Taylor, J. : In vivo study of the sickle cell phenomenon. J. Lab Clin. Med., 56: 854, 1960.

22.

Dean, J. , Schechter, A.N. : Sickle cell anemia: molecular and cellular bases of therapeutic approaches . N. Engl. J. Med., 299: 804, 1978.

23.

Jandl, J.H. , Simmons, R.L. , Castle, W.B. : Red cell filtration and the pathogenesis of certain hemolytic anemias. Blood, 18: 133, 1961.

24.

Usami, S. , Chien, S. Bertles, J.I. : Deformability of sickle cells as studies by micro-sieving J. Lab Clin. Med., 86: 274, 1975.

25.

Hebbel R.P. , Boogaerts M.A. , Eaton J.W. and Steinberg M.H. : Erythrocyte Adherence to Endothelium in sickle-cell anemia. N. Engl. J. Med., 302:992, 1980.